Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
- PMID: 15747110
- DOI: 10.1007/s00125-005-1682-x
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
Abstract
Aims/hypothesis: Non-alcoholic fatty liver disease (NAFLD) has been associated with the metabolic syndrome. However, it is not clear whether insulin resistance is an independent feature of NAFLD, and it remains to be determined which of the in vivo actions of insulin are impaired in this condition.
Methods: We performed a two-step (1.5 and 6 pmol min(-1) kg(-1)) euglycaemic insulin clamp coupled with tracer infusion ([6,6-2H2]glucose and [2H5]glycerol) and indirect calorimetry in 12 non-obese, normolipidaemic, normotensive, non-diabetic patients with biopsy-proven NAFLD and six control subjects.
Results: In NAFLD patients, endogenous glucose production (basal and during the clamp) was normal; however, peripheral glucose disposal was markedly decreased (by 30% and 45% at the low and high insulin doses, respectively, p<0.0001) at higher plasma insulin levels (p=0.05), due to impaired glucose oxidation (p=0.003) and glycogen synthesis (p<0.001). Compared with control subjects, glycerol appearance and lipid oxidation were significantly increased in NAFLD patients in the basal state, and were suppressed by insulin to a lesser extent (p<0.05-0.001). The lag phase of the in vitro copper-catalysed peroxidation of LDL particles was significantly shorter in the patients than in the control subjects (48+/-12 vs 63+/-13 min, p<0.04). Lipid oxidation was significantly related to endogenous glucose production, glucose disposal, the degree of hepatic steatosis, and LDL oxidisability.
Conclusions/interpretation: Insulin resistance appears to be an intrinsic defect in NAFLD, with the metabolic pattern observed indicating that adipose tissue is an important site.
Similar articles
-
Lipid metabolism and insulin resistance in cirrhosis.J Hepatol. 1994 Jun;20(6):782-91. doi: 10.1016/s0168-8278(05)80150-3. J Hepatol. 1994. PMID: 7930479
-
Liver fat and lipid oxidation in humans.Liver Int. 2009 Oct;29(9):1439-46. doi: 10.1111/j.1478-3231.2009.02076.x. Epub 2009 Jul 7. Liver Int. 2009. PMID: 19602132
-
Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.Gut. 2013 Nov;62(11):1625-33. doi: 10.1136/gutjnl-2012-302789. Epub 2012 Oct 17. Gut. 2013. PMID: 23077135
-
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.Nutrients. 2013 May 10;5(5):1544-60. doi: 10.3390/nu5051544. Nutrients. 2013. PMID: 23666091 Free PMC article. Review.
-
The metabolic abnormalities associated with non-alcoholic fatty liver disease.Best Pract Res Clin Gastroenterol. 2002 Oct;16(5):709-31. doi: 10.1053/bega.2002.0325. Best Pract Res Clin Gastroenterol. 2002. PMID: 12406441 Review.
Cited by
-
Gestational diabetes mellitus and development of intergenerational non-alcoholic fatty liver disease (NAFLD) after delivery: a systematic review and meta-analysis.EClinicalMedicine. 2024 Apr 29;72:102609. doi: 10.1016/j.eclinm.2024.102609. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38707911 Free PMC article.
-
The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum.Int J Mol Sci. 2024 Apr 16;25(8):4397. doi: 10.3390/ijms25084397. Int J Mol Sci. 2024. PMID: 38673981 Free PMC article. Review.
-
Oligonucleotide therapies for nonalcoholic steatohepatitis.Mol Ther Nucleic Acids. 2024 Mar 30;35(2):102184. doi: 10.1016/j.omtn.2024.102184. eCollection 2024 Jun 11. Mol Ther Nucleic Acids. 2024. PMID: 38665220 Free PMC article. Review.
-
Increased visceral fat area to skeletal muscle mass ratio is positively associated with the risk of metabolic dysfunction-associated steatotic liver disease in a Chinese population.Lipids Health Dis. 2024 Apr 14;23(1):104. doi: 10.1186/s12944-024-02100-5. Lipids Health Dis. 2024. PMID: 38616253 Free PMC article.
-
Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review).Mol Med Rep. 2024 Jun;29(6):95. doi: 10.3892/mmr.2024.13219. Epub 2024 Apr 12. Mol Med Rep. 2024. PMID: 38606791 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous